Official websites use. Share sensitive information only on official, secure websites. The objective was to update the version of the Canadian clinical practice guidelines for the management of neuropathic pain in people with spinal cord injury SCI. The guidelines are relevant for inpatient, outpatient and community SCI rehabilitation settings in Canada. A Steering Committee and Working Group reviewed the relevant evidence on neuropathic pain management encompassing screening and diagnosis, treatment and models of care after SCI.
A consensus process was followed to achieve agreement on recommendations and clinical considerations. The working group identified and reviewed 46 additional relevant articles published since the last version of the guidelines. The panel agreed on 3 new screening and diagnosis recommendations and 8 new treatment recommendations. Two key changes to these treatment recommendations included the introduction of general treatment principles and a new treatment recommendation classification system.
No new recommendations to model of care were made. Neuropathic pain NP presents significant challenges to those living with spinal cord injury SCI , with negative effects on function participation, e. The current document presents updates to the CanPainSCI CPG based on additional relevant literature that has been published since the first iteration of the guidelines.
The ongoing goals of these CPG are to 1 provide practical and actionable guidelines with a strong rating on the AGREE-II scale, 2 support standardized care in the rehabilitation management of NP after SCI, and 3 identify opportunities for further research in this area. The scope and purpose of these guidelines are unchanged from the version. The target population to which these CPG apply includes adults living with SCI who are in the subacute phase of inpatient rehabilitation management to those living in the community.
It excludes those being cared for in an acute care setting immediately after their initial injury. These guidelines are intended to be used by clinicians who care for those with SCI. Researchers and health policy experts will also find these guidelines valuable.
